brilliant news... excellent validation, massive incentive for both big pharma's and suitable CEO candidates...
add that to Orphan Drug Designation status for MPS and we look very appealing now to the big boys i would think... not that MPS and OA can't be different partners..
brilliant news... excellent validation, massive incentive for...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.0¢ | $76.72K | 326.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 197240 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 65719 | 5 |
View Market Depth
| Last trade - 13.24pm 19/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |